Robert Toto

1.4k total citations
16 papers, 594 citations indexed

About

Robert Toto is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Robert Toto has authored 16 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nephrology. Recurrent topics in Robert Toto's work include Blood Pressure and Hypertension Studies (9 papers), Diabetes Treatment and Management (6 papers) and Hormonal Regulation and Hypertension (6 papers). Robert Toto is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Diabetes Treatment and Management (6 papers) and Hormonal Regulation and Hypertension (6 papers). Robert Toto collaborates with scholars based in United States, Denmark and United Kingdom. Robert Toto's co-authors include Peter Van Buren, Jula K. Inrig, Catherine Kim, Jason D. Allen, Kristin M. D’Silva, Scott D. Solomon, Moustafa Sherief Moustafa, Eldrin F. Lewis, Luís M. Ruilope and Amy Feng and has published in prestigious journals such as American Heart Journal, American Journal of Kidney Diseases and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Robert Toto

16 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Toto United States	11	276	237	190	106	80	16	594
Frank A. Holtkamp Netherlands	6	281 1.0×	275 1.2×	240 1.3×	71 0.7×	54 0.7×	9	574
Yoichi Ohno Japan	16	180 0.7×	207 0.9×	204 1.1×	138 1.3×	87 1.1×	66	791
Gen Yasuda Japan	15	220 0.8×	317 1.3×	172 0.9×	168 1.6×	123 1.5×	73	790
Henry Punzi United States	17	180 0.7×	413 1.7×	215 1.1×	78 0.7×	105 1.3×	50	702
Giacomina Loriga Italy	8	234 0.8×	381 1.6×	146 0.8×	58 0.5×	81 1.0×	11	604
Ryu Kobayashi Japan	15	93 0.3×	227 1.0×	162 0.9×	125 1.2×	81 1.0×	42	521
Hernan Rincon-Choles United States	11	241 0.9×	121 0.5×	111 0.6×	154 1.5×	95 1.2×	22	625
Alexia Piperidou Greece	7	109 0.4×	173 0.7×	272 1.4×	121 1.1×	112 1.4×	12	607
Ch. Schnack Austria	14	113 0.4×	200 0.8×	154 0.8×	85 0.8×	53 0.7×	20	500
W. Marz Germany	10	146 0.5×	314 1.3×	248 1.3×	104 1.0×	136 1.7×	11	731

Countries citing papers authored by Robert Toto

Since Specialization

Citations

This map shows the geographic impact of Robert Toto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Toto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Toto more than expected).

Fields of papers citing papers by Robert Toto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Toto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Toto. The network helps show where Robert Toto may publish in the future.

Co-authorship network of co-authors of Robert Toto

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Toto. A scholar is included among the top collaborators of Robert Toto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Toto. Robert Toto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Heerspink, Hiddo J.L., David C. Wheeler, Ricardo Correa-Rotter, et al.. (2023). #3382 REASONS FOR DIALYSIS INITIATION AND SAFETY OF DAPAGLIFLOZIN AMONG DIALYSIS PARTICIPANTS: NEW INSIGHTS FROM DAPA-CKD. Nephrology Dialysis Transplantation. 38(Supplement_1). 4 indexed citations

Sarafidis, Pantelis, Rajiv Agarwal, Bertram Pitt, et al.. (2023). Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 18(5). 602–612. 25 indexed citations

Toto, Robert & George L. Bakris. (2022). The FIDELIO Study Podcast. Diabetes Therapy. 13(5). 823–828. 1 indexed citations

Agarwal, Rajiv, Stefan D. Anker, Bertram Pitt, et al.. (2021). Importance of trial design when investigating cardiorenal outcomes in patients with CKD and T2D: Focus on CREDENCE and FIDELIO-DKD. American Heart Journal. 242. 162–162. 1 indexed citations

Agarwal, Rajiv, Stefan D. Anker, Gerasimos Filippatos, et al.. (2021). Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrology Dialysis Transplantation. 37(7). 1261–1269. 36 indexed citations

Neyra, Javier A., et al.. (2016). Comparison of Ambulatory Blood Pressure Patterns in Patients With Intradialytic Hypertension and Hemodialysis Controls. Kidney & Blood Pressure Research. 41(3). 240–249. 14 indexed citations

Zeeuw, Dick de, Dennis L. Andress, John J. Brennan, et al.. (2015). Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. European Journal of Preventive Cardiology. 23(7). 758–768. 30 indexed citations

Inrig, Jula K., Kristin M. D’Silva, Catherine Kim, et al.. (2014). Effect of Low Versus High Dialysate Sodium Concentration on Blood Pressure and Endothelial-Derived Vasoregulators During Hemodialysis: A Randomized Crossover Study. American Journal of Kidney Diseases. 65(3). 464–473. 48 indexed citations

Toto, Robert, et al.. (2012). Current Update in the Management of Diabetic Nephropathy. Current Diabetes Reviews. 9(1). 62–77. 51 indexed citations

10.

Toto, Robert. (2012). Dyslipidemia in dialysis patients. 461–472. 1 indexed citations

11.

Buren, Peter Van, Catherine Kim, Robert Toto, & Jula K. Inrig. (2011). Intradialytic Hypertension and the Association with Interdialytic Ambulatory Blood Pressure. Clinical Journal of the American Society of Nephrology. 6(7). 1684–1691. 65 indexed citations

12.

Buren, Peter Van & Robert Toto. (2011). Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management. Advances in Chronic Kidney Disease. 18(1). 28–41. 162 indexed citations

13.

Lewis, Eldrin F., Marc A. Pfeffer, Amy Feng, et al.. (2011). Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease. Clinical Journal of the American Society of Nephrology. 6(4). 845–855. 44 indexed citations

14.

Toto, Robert, et al.. (2006). Epithelial Sodium Channel Inhibition in Cardiovascular DiseaseA Potential Role for Amiloride. American Journal of Hypertension. 20(1). 109–117. 63 indexed citations

15.

Toto, Robert. (2004). Lessons learned from recent clinical trials in hypertensive diabetics: What?s good for the kidney is good for the heart and brain. American Journal of Hypertension. 17(11 Pt 2). S7–S10. 5 indexed citations

16.

Toto, Robert. (2001). Angiotensin II Subtype 1 Receptor Blockers and Renal Function. Archives of Internal Medicine. 161(12). 1492–1492. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact